[ad_1]
On the 21st (local time) in the United States, the cumulative number of corona 19 infections exceeded 12 million. The cumulative number of confirmed cases surpassed 11 million on the 15th, with another million added in just 6 days.
Thanksgiving (26) is a climax
U.S. CDC expects 50 million travelers to refrain from moving
According to Reuters on the 21st The United States accounts for 20.8% of accumulated infections worldwideOccupy. The cumulative death toll of Corona 19 in the United States is approximately 250,000, representing 18.5% of the world.
Debbie Bucks, coordinator of the White House Corona 19 Task Force (TF), told CNN that it was “faster and more widespread (than the previous outbreak),” and emphasized that the growth rate of the infection is markedly different. to the previous one.
In fact, since January 20, when the first coronavirus was confirmed in the United States, it took 98 days to exceed 1 million (April 28), compared to the rapid rate of spread.
When things get serious The U.S. Food and Drug Administration (FDA) approved the emergency use of the treatment that President Donald Trump had given him when he had Corona 19. According to Bloomberg News on the 21st, ‘REGN-COV2’, a monoclonal antibody treatment from the American biotechnology company Regeneron, was approved.
The FDA has approved urgent use in the treatment of COVID-19 patients (including high-risk groups older than 65 years) with mild or moderate symptoms older than 12 years. According to the FDA, in clinical trials in COVID-19 patients, patients who received the drug were less likely to be hospitalized for COVID-19 symptoms or to go to the emergency room within 28 days of starting the drug. compared to the control group that took placebo (placebo).
This treatment is a drug that was administered to President Trump, who was hospitalized after becoming infected with Corona 19 last month, along with dexamethasone and remdesivir. President Trump called this remedy “God’s blessing.”
This is the second time the FDA has approved it as a monoclonal antibody treatment, the Washington Post reported. Previously, the FDA approved emergency use on day 9, saying that the monoclonal antibody treatment ‘LY-CoV555’, which is being developed by the American pharmaceutical company Eli Lilly, in cooperation with a Canadian biotech company, can be used to mild patients with Corona 19.
Ahead Thanksgiving Day (26), the most important holiday in the United StatesThis is expected to be the case. This is because the spread of Corona 19 can accelerate the movement of many.
Although experts like the Centers for Disease Control and Prevention (CDC) recommend refraining from moving around, Chicago O’Hare International Airport, which is called the hub of air travel, is packed with tourists. During Thanksgiving, the number of travelers in the United States is expected to reach 50 million.
In the midst of this, the US CDC released a report on the 20th (local time) that analyzed that more than half of corona transmission is asymptomatic or before symptoms appear.
According to the report, 24% of those who transmit the coronavirus to other people do not have any symptoms and 35% are in the pre-onset stage. In other words, 59% of cases spread Corona 19 when infected people have no symptoms.
The remaining 41% are symptoms of a cough and high fever. With so many asymptomatic infections, the CDC emphasized that the way to prevent corona is by wearing a mask.
The CDC repeatedly emphasized the importance of wearing a mask, saying that wearing a mask has the effect of blocking up to 50-70% of the drops. The CDC analyzed that “if you increase the use of masks to 15%, you can avoid lockdowns and reduce losses of 5% of gross domestic product (GDP), up to $ 1 trillion.”
Reporter Seo Yujin [email protected]
[ad_2]